3174 results for «533»
3174 results
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
Complex mitral interventions
19 Nov 2023 – From PCR London Valves 2023
What are the one-year outcomes of transfemoral TMVR? How does TMVI compare with SMVR in elderly patients at intermediate risk? What is the value of mitral ViV and mitral valve-in-ring in high-surgical-risk patients? Find the answers here!
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
TAVI for aortic regurgitation
19 Nov 2023 – From PCR London Valves 2023
In the face of aortic regurgitation, learn about various TAVI rescue techniques in this session, including valve implantation in the descending aorta, TAVI treatment of aortic regurgitation with cardiogenic shock, and TAVI management of aortic regurgitation in a patient with a left ventricular assist device.
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
TAVI failure - Mechanisms and management
19 Nov 2023 – From PCR London Valves 2023
Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!
Prevention and treatment of left ventricular outflow tract obstruction
19 Nov 2023 – From PCR London Valves 2023
Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!
TAVI with challenging femoral access
19 Nov 2023 – From PCR London Valves 2023
Learn how to perform transfemoral TAVI using orbital atherectomy, insert a self-expanding valve through a tortuous and calcified aorta, or navigate through calcified vessels or kinked aorta thanks to the techniques presented in this session, among others.
TAVI - New indications, techniques and devices - Part 1
19 Nov 2023 – From PCR London Valves 2023
STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden
25 Oct 2025
Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.
Author
